Infusion therapy devices are being widely used in hospitals and clinics for the treatment of multiple chronic conditions. Generally, a trained user operates the infusion devices in order to program the rate and duration of fluid delivery with a built-in software interface. Due to the availability of skilled professionals, patients opt for hospitals for treatment of their chronic conditions. This, in turn, is encouraging the demand for infusion therapy devices in hospitals that are equipped with software that can enable professionals while taking point-of-care decisions. Infusion therapy devices enable to deliver appropriate medications or nutrients, including antibiotics, chemotherapy, insulin or other hormones, and pain relievers that raises its demand in hospitals.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/infusion-therapy-devices-market-size
The global infusion therapy devices market has been witnessed optimistic growth due to the rising number of surgeries performed in hospitals and clinics and a significant prevalence of chronic diseases. For instance, according to the International Diabetes Federation (IDF), in 2017, nearly 425 million adults, aged over 20 years, were living with diabetes. This number is estimated to rise significantly and would reach to 629 million by 2045. In addition, the proportion of people with type 2 diabetes is increasing in most countries, registering around 79% of adults with diabetes living in low- and middle-income countries. This results in the rising demand for infusion devices, such as infusion pumps for the treatment of diabetic patients.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size
Growing awareness of chronic diseases in emerging economies
Growing awareness of chronic diseases treatment in emerging economies, such as China and India, provides substantial growth opportunity for the infusion therapy device market. Due to the rise in cancer mortalities, the government is actively working towards developing awareness for cancer. For instance, since 1987, the Indian Cancer Society has conducted over 5,000 Cancer Awareness Programs which have benefited more than 6,35,000 participants. This, in turn, is anticipated to increase awareness among people for early diagnosis and treatment of the condition at an early stage that can increase their survival rate. Thus, this raises the demand for infusion therapy devices for the treatment of cancer patients that contribute to the growth of the market.
Global Infusion Therapy Devices Market- Segmentation
By Product Type
- Infusion Pumps
- Consumables & Accessories
By Application
- Oncology
- Diabetes
- Gastroenterology
- Analgesia
- Hematology
- Others (Pediatrics)
By End-User
- Hospitals
- Homecare
- Ambulatory Surgery Centers
Global Infusion Therapy Devices Market– Segment by Region
North America
- The US
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- Agiliti Health, Inc.
- Avanos Medical, Inc.
- Braun Melsungen AG
- Baxter International, Inc.
- Becton, Dickinson and Co.
- Caesarea Medical Electronics Ltd.
- Clinical Resources, Inc.
- CME America, LLC
- Fresenius SE & Co. KGaA
- ICU Medical, Inc.
- Infuserve America Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
